SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-17-002187
Filing Date
2017-07-31
Accepted
2017-07-31 15:32:31
Documents
9
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 6-K zk1720311.htm 6-K 18071
2 OPINION OF YIGAL ARNON & CO. exhibit_5-1.htm EX-5.1 46753
3 OPINION OF MORRISON & FOERSTER LLP exhibit_5-2.htm EX-5.2 16060
4 SUBSCRIPTION AGREEMENT exhibit_10-1.htm EX-10.1 113776
5 FORM OF SERIES A WARRANT exhibit_10-2.htm EX-10.2 106245
6 FORM OF SERIES B WARRANT exhibit_10-3.htm EX-10.3 106370
7 VOTING AND STANDSTILL AGREEMENT exhibit_10-4.htm EX-10.4 44645
8 image0.jpg GRAPHIC 107874
9 image00003.jpg GRAPHIC 20777
  Complete submission text file 0001178913-17-002187.txt   630392
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 17992845
SIC: 2834 Pharmaceutical Preparations